AC104534.3 | Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | | | | | | Tissue enhanced |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADORA2A | Adenosine A2a receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
AL353354.2 | | Predicted secreted proteins
| | | | | Tissue enhanced |
AL359693.1 | | | | | | | Tissue enhanced |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
ANKRD18A | Ankyrin repeat domain-containing protein 18A | | | | | | Tissue enhanced |
ANKRD18B | Ankyrin repeat domain 18B | | | | | | Tissue enhanced |
AP003733.1 | Uncharacterized protein; cDNA FLJ36460 fis, clone THYMU2014801 | | | | | | Tissue enhanced |
AP5B1 | Adaptor-related protein complex 5, beta 1 subunit | | | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | | | | | | Tissue enhanced |
APOBEC3B | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | | | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ASTL | Astacin-like metallo-endopeptidase (M12 family) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ATAD5 | ATPase family, AAA domain containing 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
ATP8B4 | ATPase, class I, type 8B, member 4 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BCL2A1 | BCL2-related protein A1 | Cancer-related genes
| | | | | Tissue enhanced |
BST1 | Bone marrow stromal cell antigen 1 | CD markers Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C11orf21 | Chromosome 11 open reading frame 21 | | | | | | Tissue enhanced |
C16orf54 | Chromosome 16 open reading frame 54 | Predicted membrane proteins
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | | | | | | Tissue enhanced |
C19orf38 | Chromosome 19 open reading frame 38 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf228 | Chromosome 1 open reading frame 228 | | | | | | Tissue enhanced |
C2orf48 | Chromosome 2 open reading frame 48 | | | | | | Tissue enhanced |
C5orf66 | Chromosome 5 open reading frame 66 | | | | | | Tissue enhanced |
CARD9 | Caspase recruitment domain family, member 9 | Disease related genes
| | | | | Tissue enhanced |
CBX4 | Chromobox homolog 4 | | | | | | Tissue enhanced |
CCL3 | Chemokine (C-C motif) ligand 3 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL3L1 | Chemokine (C-C motif) ligand 3-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL3L3 | Chemokine (C-C motif) ligand 3-like 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL4 | Chemokine (C-C motif) ligand 4 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL4L1 | Chemokine (C-C motif) ligand 4-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL4L2 | Chemokine (C-C motif) ligand 4-like 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes
| | | | | Tissue enhanced |
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | Enzymes
| | | | | Tissue enhanced |
CD300E | CD300e molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CDA | Cytidine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | | | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | | | | | | Tissue enhanced |
CEACAM3 | Carcinoembryonic antigen-related cell adhesion molecule 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CENPU | Centromere protein U | | | | | | Tissue enhanced |
CFP | Complement factor properdin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | | | | | | Tissue enhanced |
CLC | Charcot-Leyden crystal galectin | | | | | | Tissue enhanced |
CLEC12A | C-type lectin domain family 12, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4E | C-type lectin domain family 4, member E | Predicted membrane proteins
| | | | | Tissue enhanced |